Research and Clinical Trials
Wyeth is a global leader in pharmaceuticals, consumer health care products, and animal health care products.
An outstanding, preeminent capability in research and development tops the list of Wyeth corporate strengths. Our research and development strategy is to continue to invest in innovative products, which are essential to the long-term success of health care companies which meet the needs of the patients and doctors we serve. In 2006, Wyeth spent approximately $3.1 billion on research and development, with an emphasis on pharmaceutical, vaccine and biopharmaceutical approaches to treating and preventing disease. This level of spending places Wyeth among the world's leading pharmaceutical companies.
Wyeth Research organizes the efforts of our employees worldwide in the search for and development of new drugs that will enhance both the quality of health care and the Wyeth product line. Research departments include:
- Pharmaceutical Research and Development
- Biopharmaceuticals
- Vaccines Research and Development
- Consumer Health Global Scientific Affairs
- Fort Dodge Animal Health Research and Development
Our commitment to research and development demonstrates our focus on the future. Our goal is to consistently produce new, innovative treatments that provide the world with a healthier tomorrow.
119291-00